What is SPRINGBUK?
Springbuk operates as a Health Intelligence platform, leveraging data to deliver actionable strategies that empower employers and consultants to make more informed health management decisions. Based in Indianapolis, Indiana, the company's core offering focuses on providing insights that drive efficiency and effectiveness in corporate wellness and healthcare expenditure. The platform's ability to translate complex health data into practical guidance is a key differentiator in the market.
How much funding has SPRINGBUK raised?
SPRINGBUK has raised a total of $25.8M across 3 funding rounds:
Series A
$3.8M
Series B
$20M
Debt
$2M
Series A (2016): $3.8M with participation from Lewis & Clark Venture Capital
Series B (2017): $20M led by HealthQuest Capital
Debt (2020): $2M supported by PPP
Key Investors in SPRINGBUK
HealthQuest Capital
HealthQuest Capital is a venture capital firm that invests in the healthcare industry, likely focusing on companies that leverage technology to improve health outcomes and reduce costs.
Lewis & Clark Venture Capital
Lewis & Clark Venture Capital is an early-stage venture firm that partners with visionary founders to build iconic B2B software companies, typically investing in late seed through Series A companies.
PPP
Public-Private Partnership
What's next for SPRINGBUK?
The substantial enterprise-level funding received by SPRINGBUK signals a strategic push towards scaling operations and enhancing its Health Intelligence platform. This capital infusion is expected to fuel product development, expand market reach, and potentially explore new strategic partnerships. The company's focus on data-driven decision-making in healthcare management positions it to capitalize on the growing demand for efficient and effective employee health solutions.
See full SPRINGBUK company page
